You are here: Industry Insights > Treatment

News List

A New Way to Fight a Previously 'Inoperable' Pancreatic Cancer drugs
May 31, 2019
A New Way to Fight a Previously 'Inoperable' Pancreatic Cancer.
FDA Approves Jakafi (ruxolitinib) for the Treatment of Patients with Acute Graft-Versus-Host Disease drugs
May 29, 2019
Incyte Corporation today announced that the U.S. Food and Drug Administration (FDA) has approved Jakafi (ruxolitinib) for the treatment of steroid-refractory acute GVHD in adult and pediatric patients 12 years and older.
Racial Disparity Seen in Prescriptions for Buprenorphine drugs
May 21, 2019
Racial Disparity Seen in Prescriptions for Buprenorphine.
Recs Updated for TB Screening, Treatment in Health Care Workers drugs
May 17, 2019
Recs Updated for TB Screening, Treatment in Health Care Workers.
NHS improvements to give patients faster access to pioneering treatments pharmatimes
May 09, 2019
NHS improvements to give patients faster access to pioneering treatments.
New Treatment Guideline Focuses on Tourette Syndrome drugs
May 09, 2019
New Treatment Guideline Focuses on Tourette Syndrome.
EU approval for Sanofi’s type 2 diabetes treatment europeanpharmaceuticalreview
May 08, 2019
Suliqua is an innovative new combination therapy that has the potential to address significant unmet needs for people living with type 2 diabetes in Europe
World Asthma Day: can fevipiprant revolutionise asthma treatment? pharmaceutical-technology
May 07, 2019
World Asthma Day aims to raise awareness of the burden of asthma. Increasingly, the standard of care for asthma, reliever and preventer inhalers, are being discovered to be insufficient in a number of ways.
Anti-malaria drug shows promise as Zika virus treatment europeanpharmaceuticalreview
May 05, 2019
Chloroquine found to reduced the amount of Zika virus in maternal blood and neural progenitor cells in the foetal brain.
Cabozantinib shows promise as first line treatment for differentiated thyroid cancer europeanpharmaceuticalreview
May 05, 2019
A kinase inhibitor called cabozantinib could be a viable therapy option for patients with metastatic, radioactive iodine-resistant thyroid cancer…

Previous page 1 2 3 4 5 6 7 8 9 10 ... 14 15 Next page